SIMPONI SC Managed Access Program
Latest Information Update: 18 Apr 2023
At a glance
- Drugs Golimumab (Primary)
- Indications Type 1 diabetes mellitus
- Focus Expanded access; Therapeutic Use
- Sponsors Janssen Research & Development
Most Recent Events
- 11 Apr 2023 Status changed from recruiting to completed.
- 16 May 2019 New trial record